- AMGN -0.39%
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
Yahoo Finance · 3 months ago
Gilead Sciences
Search results
- 334.30Add to watchlist-1.31 (-0.39%)At close:4:00 PM EDTThu. Jul 25, 2024335.02 +0.72 (+0.22%)Pre mkt:4:33 AM EDTFri. Jul 26, 2024Nasdaq Real Time Price (USD) · Pre-Market Time
- Open335.99High346.85Low333.02
- Mkt Cap179.33BP/E (TTM)47.83Div & Yield9.00 & 2.69%
- Prev. Close335.6152 Wk. Low228.2152 Wk. High346.85
What analysts are sayingTop storiesRelated stocks
Find the latest Earnings Report Date for Amgen Inc. Common Stock (AMGN) at Nasdaq.com.
- Option Chain
View the most recent data and latest information on option...
- Analyst Research
Based on analysts offering 12 month price targets for AMGN...
- P/E & Peg Ratios
Get updated information on Amgen Inc. Common Stock (AMGN)...
- Option Chain
May 3, 2024 · Amgen Inc (NASDAQ:AMGN) reported strong sales growth of 22% year-over-year in the first quarter, driven by robust volume growth across its four therapeutic pillars.
Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
3 days ago · Amgen has generated $7.00 earnings per share over the last year ($7.00 diluted earnings per share) and currently has a price-to-earnings ratio of 47.7. Earnings for Amgen are expected to grow by 5.74% in the coming year, from $19.50 to $20.62 per share.
- 345 N Reid Place, Suite 620, Sioux Falls, 57103, SD
- contact@marketbeat.com
- (844) 978-6257
- Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 30th, 2024 based off last...
- In the previous quarter, Amgen (NASDAQ:AMGN) reported $4.96 earnings per share (EPS) to beat the analysts' consensus estimate of $4.65 by $0.31. Le...
- The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call
- The conference call transcript for Amgen's latest earnings report can be read online. Read Transcript
- Amgen (NASDAQ:AMGN) has a recorded annual revenue of $26.32 billion.
- Amgen (NASDAQ:AMGN) has a recorded net income of $6.55 billion. AMGN has generated $14.07 earnings per share over the last four quarters.
- Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 21.54 and a forward price-to-earnings ratio of 16.26. The price/earnings-to-growth ra...
- Amgen's earnings are expected to grow from $18.64 per share to $19.83 per share in the next year, which is a 6.38% increase.
Jul 16, 2024 · For their last quarter, Amgen (AMGN) reported earnings of $3.96 per share, beating the Zacks Consensus Estimate of $3.76 per share. This reflects a positive earnings surprise of 5.32%.
May 2, 2024 · Key results include: For the first quarter, total revenues increased 22% to $7.4 billion in comparison to the first quarter of 2023. Product sales grew 22%, driven by 25% volume growth.
People also ask
When is Amgen's next earnings report?
How did Amgen (AMGN) perform in the last quarter?
What is AMGN's earnings quality ranking?
What to expect from AMGN's next earnings release?
Get the latest Amgen Inc (AMGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
